Hyperuricemia is accompanied by elevated peripheral CD4+ T cells

[1]  Zhilei Wang,et al.  Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout , 2022, Frontiers in Cellular and Infection Microbiology.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  Moon-Ho Park,et al.  A retrospective observational study , 2020 .

[4]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[5]  R. Keenan.  The biology of urate. , 2020, Seminars in arthritis and rheumatism.

[6]  O. Woodward,et al.  Sex Differences in Urate Handling , 2020, International journal of molecular sciences.

[7]  Chunyan Liu,et al.  Advances in the role of helper T cells in autoimmune diseases , 2020, Chinese medical journal.

[8]  L. Joosten,et al.  Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia , 2019, Immunological reviews.

[9]  D. M. Richards,et al.  Concepts for agonistic targeting of CD40 in immuno-oncology , 2019, Human vaccines & immunotherapeutics.

[10]  T. Merriman,et al.  Gout, Hyperuricemia, and Crystal‐Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout , 2019, Arthritis care & research.

[11]  E. Lee,et al.  Influence of androgen deprivation therapy on serum urate levels in patients with prostate cancer: A retrospective observational study , 2018, PloS one.

[12]  N. Chen,et al.  White blood cell count and the incidence of hyperuricemia: insights from a community-based study , 2018, Frontiers of Medicine.

[13]  T. Merriman,et al.  Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. , 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  K. Nadeau,et al.  Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. , 2018, Journal of hepatology.

[15]  T. Nakayama,et al.  Maintenance of pathogenic Th2 cells in allergic disorders. , 2017, Allergology international : official journal of the Japanese Society of Allergology.

[16]  Takashi Saito,et al.  CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function , 2017, Front. Immunol..

[17]  L. Miao,et al.  Induction of ROS Overload by Alantolactone Prompts Oxidative DNA Damage and Apoptosis in Colorectal Cancer Cells , 2016, International journal of molecular sciences.

[18]  Yuquan Wei,et al.  Uric acid enhances the antitumor immunity of dendritic cell-based vaccine , 2015, Scientific Reports.

[19]  Z. Ye,et al.  Soluble monosodium urate, but not its crystal, induces toll like receptor 4-dependent immune activation in renal mesangial cells. , 2015, Molecular immunology.

[20]  M. Oosting,et al.  Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra , 2015, Annals of the rheumatic diseases.

[21]  G. Gamble,et al.  Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study , 2015, Annals of the rheumatic diseases.

[22]  P. Richette,et al.  Definition of hyperuricemia and gouty conditions , 2014, Current opinion in rheumatology.

[23]  M. Gershwin,et al.  The X chromosome and immune associated genes. , 2012, Journal of autoimmunity.

[24]  G. López-Castejón,et al.  Understanding the mechanism of IL-1β secretion , 2011, Cytokine & growth factor reviews.

[25]  B. Álvarez-Lario,et al.  Uric acid and evolution. , 2010, Rheumatology.

[26]  Henk C. Hoogsteden,et al.  Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells , 2008, The Journal of experimental medicine.

[27]  K. Knutson,et al.  The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity. , 2008, Blood.

[28]  S. Bandinelli,et al.  Uric acid and inflammatory markers. , 2006, European heart journal.

[29]  L. Thomsen,et al.  Uric Acid Promotes Tumor Immune Rejection , 2004, Cancer Research.

[30]  James E. Evans,et al.  Molecular identification of a danger signal that alerts the immune system to dying cells , 2003, Nature.

[31]  P. Chou,et al.  The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. , 2000, The Journal of rheumatology.